Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

UT-15 to be reviewed by FDA advisory committee; promising clinical data reported

Nov. 14, 2000

Selective cGMP-PDE inhibitors synthesized at Nippon Soda

Nov. 13, 2000

First clinical trial begins for novel HDL therapy

Nov. 13, 2000

In vivo interactions between coronary vasodilators S-nitrosocaptopril and nitroglycerin

Nov. 10, 2000

Forest to market Recordati's lercanidipine in U.S.

Nov. 10, 2000

Merck issued patent covering new anticoagulants

Nov. 8, 2000

SBIR grant awarded to MetaPhore for human septic shock study

Nov. 8, 2000

Medicure licenses cardiovascular therapeutics from George Washington University

Nov. 7, 2000

Preparation, activity and use of new cGMP-PDE inhibitors in cardiovascular and other disorders

Nov. 6, 2000

Glaxo Wellcome granted rights to Zambon's ACE/NEP inhibitor

Nov. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...